CLOFARABINE, MELPHALAN AND THIOTEPA REDUCED-INTENSITY CONDITIONING CHEMOTHERAPY ALONG WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE-BASED GRAFT VERSUS HOST DISEASE PROPHYLAXIS FOR ALLOGENEIC STEM CELL TRANSPLANT

被引：0
|
作者：
Verduzco, Alejandro Del Rio [1 ]
Go, Aileen [1 ]
Kodali, Murali [1 ]
Ulrickson, Matthew [1 ]
De Padova, Nicolas [1 ]
Smith, Eric [1 ]
Komerdelj, Ivan [1 ]
Heers, Hayley [1 ]
Brookes, Jennifer [1 ]
Pebler, Haley [1 ]
Yasuda, Rachael [1 ]
Nath, Rajneesh [1 ]
机构：
[1] Banner MD Anderson Canc Ctr, Gilbert, AZ USA
来源：
BONE MARROW TRANSPLANTATION | 2024年 / 59卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P202
引用
收藏
页码：283 / 284
页数：2
相关论文
共 50 条
  • [41] Post-Transplant Cyclophosphamide for Graft Versus Host Disease Prophylaxis in Alternative Donor Stem Cell Transplantation: Immune Reconstitution and Infection Risk
    Nagler, Arnon
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (11): : 883 - 884
  • [42] Myeloablative and reduced-intensity conditioning in HLA-haploidentical peripheral blood stem cell transplantation using post-transplant cyclophosphamide
    Sugita, Junichi
    Kagaya, Yusuke
    Miyamoto, Toshihiro
    Shibasaki, Yasuhiko
    Nagafuji, Koji
    Ota, Shuichi
    Furukawa, Tatsuo
    Nara, Miho
    Akashi, Koichi
    Taniguchi, Shuichi
    Harada, Mine
    Matsuo, Keitaro
    Teshima, Takanori
    BONE MARROW TRANSPLANTATION, 2019, 54 (03) : 432 - 441
  • [43] POST-TRANSPLANT CYCLOPHOSPHAMIDE IS ASSOCIATED WITH REDUCED RATE OF SECONDARY MALIGNANCIES POST ALLOGENEIC STEM CELL TRANSPLANT
    Desai, Nihar
    Pereira, Mariana Pinto
    Remberger, Mats
    Kumar, Rajat
    Kim, Dennis
    Viswabandya, Auro
    Law, Arjun
    Lam, Wilson
    Pasic, Ivan
    Gerbitz, Armin
    Novitzky-Basso, Igor
    Mattsson, Jonas
    Michelis, Fotios
    BONE MARROW TRANSPLANTATION, 2024, 59 : 584 - 585
  • [44] Reduced Intensity Conditioning for Allogeneic Hematopoietic Stem-Cell Transplant Determines the Kinetics of Acute Graft-Versus-Host Disease
    Turner, Brie E.
    Kambouris, Melinda E.
    Sinfield, Laura
    Lange, Janusz
    Burns, Ann M.
    Lourie, Rohan
    Atkinson, Kerry
    Hart, Derek N. J.
    Munster, David J.
    Rice, Alison M.
    TRANSPLANTATION, 2008, 86 (07) : 968 - 976
  • [45] Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors
    Shaffer, Brian C.
    Gooptu, Mahasweta
    Defor, Todd E.
    Maiers, Martin
    Bolanos-Meade, Javier
    Abboud, Ramzi
    Briggs, Adrienne D.
    Khimani, Farhad
    Modi, Dipenkumar
    Newcomb, Richard
    Shpall, Elizabeth J.
    Bupp, Caitrin
    Spellman, Stephen R.
    Stefanski, Heather E.
    Shaw, Bronwen E.
    Auletta, Jeffery J.
    Devine, Steven M.
    Jimenez, Antonio M. Jimenez
    Al Malki, Monzr M.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (28)
  • [46] Outcomes of Allogeneic Transplantation with Clofarabine and Post-Transplant Cyclophosphamide-Based Conditioning in Patients with Very High-Risk Acute Myeloid Leukemia
    Garcia, Lucia Castilla
    Bailen, Rebeca
    Luna, Ignacio Alberto Gomez Centurion
    Fernandez-Caldas, Paula
    De Tena, Pablo Silva
    Martinez-Laperche, Carolina
    Anguita, Javier
    Garcia-Sanz, Ramon
    Kwon, Mi
    BLOOD, 2024, 144 : 4889 - 4890
  • [47] Impact of graft versus host disease prophylaxis on outcomes of unmanipulated haploidentical stem cell transplantation: post-transplant cyclophosphamide versus antithymocyte globulin based regimen
    Ruggeri, A.
    Sun, Y.
    Labopin, M.
    Lorentino, F.
    Bacigalupo, A.
    Arcese, W.
    Santarone, S.
    Gulbas, Z.
    Blaise, D.
    Irrera, G.
    Ghavamzadeh, A.
    Malard, F.
    Bruno, B.
    Diez-Martin, J. L.
    Koc, Y.
    Ciceri, F.
    Mohty, M.
    Nagler, A.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S27 - S27
  • [48] Chronic graft-versus-host disease after allogeneic reduced-intensity conditioning haematopoietic stem cell transplantations
    Michallet, M.
    Le, Q.
    Raus, N.
    Sobh, M.
    Revesz, D.
    Thiebaut, A.
    Thomas, X.
    Chelgoum, Y.
    Ducastelle, S.
    Troncy, J.
    Clark, M.
    Nicolini, F.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S119 - S119
  • [49] Myeloablative busulfan/cytoxan conditioning versus reduced-intensity fludarabine/melphalan conditioning for allogeneic hematopoietic stem cell transplant in patients with acute myelogenous leukemia
    Dhere, Vishal
    Edelman, Scott
    Waller, Edmund K.
    Langston, Amelia
    Graiser, Michael
    Connolly, Erin C.
    Switchenko, Jeffrey M.
    Esiashvili, Natia
    Khan, Mohammad K.
    LEUKEMIA & LYMPHOMA, 2018, 59 (04) : 837 - 843
  • [50] Reduced Intensity Conditioning followed by Haploidentical Hematopoietic Cell Transplantation (Ric-haploHCT) and post-transplant Cyclophosphamide as Graft versus Host Disease Prophylaxis, for Hematological Disorders: Single Centre Experience
    Patil, Vinod
    Sukumaran, Reghu
    Roychowdhury, Mita
    Chaudhuri, Sayak
    Kumar, Jeevan
    Bhave, Saurabh
    Javed, Rizwan
    Ghara, Niharendu
    Nair, Reena
    Radhakrishnan, Vivek
    Chandy, Mammen
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 312 - 313
12345